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ABSTRACT  
We previously identified dipeptidyl-peptidase 10 (DPP10) on chromosome 2 as a 
human asthma susceptibility gene, through positional cloning. Initial association 
results were confirmed in many subsequent association studies but the functional role 
of DPP10 in asthma remains unclear.  Using the MRC Harwell N-ethyl-N-nitrosourea 
(ENU) DNA archive, we identified a point mutation in Dpp10 that caused an amino 
acid change from valine to aspartic acid in the β propeller region of the protein. Mice 
carrying this point mutation were recovered and a congenic line was established 
(Dpp10145D). Macroscopic examination and lung histology revealed no significant 
differences between wild-type and Dpp10145D/145D mice.  However, after house dust 
mite (HDM) treatment, Dpp10 mutant mice showed significantly increased airway 
resistance in response to 100 mg/ml methacholine. Total serum IgE levels and 
bronchoalvelar lavage (BAL) eosinophil counts were significantly higher in 
homozygotes than control mice after HDM treatment. DPP10 protein is present in 
airway epithelial cells and altered expression is observed in both tissue from asthmatic 
patients and in mice following HDM challenge. Moreover knockdown of DPP10 in 
human airway epithelial cells, results in altered cytokine responses. These results 
show that a Dpp10 point mutation leads to increased airway responsiveness following 
allergen challenge and provide biological evidence to support previous findings from 
human genetic studies. 
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INTRODUCTION  
Asthma is characterized by intermittent inflammation of the large airways in the lungs 
with symptoms of wheeze and shortness of breath. The disease is caused by a 
combination of genetic and environmental factors.  Previously, we have established 
that polymorphisms in DPP10 on human chromosome 2 were associated with asthma 
traits through positional cloning (1). These associations have since been replicated in 
different ethnic populations worldwide (2-6). To date, DPP10 is the only gene found 
to show asthma association by both positional cloning and genome-wide association 
studies (GWAS) (6). DPP10 encodes a single-pass type II membrane protein that is a 
member of the S9B family in clan SC of the serine proteases. It has no detectable 
protease activity in mammals due to the absence of a conserved serine residue 
normally present in the catalytic domain of these proteases (7). Instead, DPP10 has 
been shown to bind specific voltage-gated potassium channels altering their 
expression and biophysical properties (8). Although DPP10 has been associated with 
asthma in both genome-wide and wet-lab studies (1, 9, 10), its functional role in 
asthma is almost completely unknown, due in large part to the absence of any genetic 
models.  
Mouse mutants are powerful experimental tools for the study of complex 
diseases, such as asthma. They have been of great benefit for mapping quantitative 
traits (11, 12), and serve as experimental tools to dissect the functional roles of genes 
in vivo (13).   Dpp10145D mice were generated using N-ethyl-N-nitrosourea (ENU) 
induced mutagenesis of the mouse genome, which is a conventional method employed 
for functional analysis (14).  
To investigate the function of DPP10 in vivo, we obtained full-length mouse 
Dpp10 cDNA. We then sequenced four out of the 26 exons of Dpp10 in 3840 mouse 
DNA samples from the UK MRC Harwell archive of ENU mutagenized F1 DNA 
samples. The four exons chosen for sequencing include the regions encoding the 
trans-membrane and β propeller domains of Dpp10, both of which are thought to be 
required for proper protein function (1). Here, we report the establishment of a novel 
mouse mutant carrying a DPP10 point mutation and its effects on experimental 
asthma.  
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METHODS 
 
Full-length cDNA of Dpp10 and exon sequencing 
A mouse cDNA clone (BE862767) was obtained and extended 5’ and 3’ ends to a 
full-length cDNA using RACE (CLONTECH). The primary transcript encodes a 
novel 2,370 bp open reading frame (ORF) with a predicted peptide sequence of 789 
residues. To identify mutations in Dpp10, we screened 4 exons of Dpp10 (2, 5, 6 and 
7) in 3840 mutagenised BALB/C DNA samples from the UK MRC Harwell ENU 
archive by sequencing the PCR products. Exon 2 encodes the trans-membrane amino 
acids and exon 5, 6, and 7 encode the first and second beta propellers of the peptide. 
PCR primer sequences are listed in supplemental table 1. PCR conditions were as 
follows: 35 cycles consisting of (i) 60 s at 94 °C, followed by (ii) 60 s at 50–60 °C 
and then (iii) 30 s at 72 ° C. PCR products from all 3840 DNA samples were purified 
with Millipore purification plates and sequenced using ABI 3700 sequence machine. 
Sequence traits were aligned and DNA samples carrying mutations were identified. 
The mutation predicted to most likely affect function was used to establish the DPP10 
mouse line.  
 
Mouse line recovery and maintenance  
Mice were housed and maintained in accordance with the rules and regulations of the 
UK Animals (Scientific Procedures) Act 1986, and the Harwell Animal Welfare and 
Ethical Review Body (AWERB). Mice were maintained in specific pathogen-free 
conditions and provided food and water ad libitum. Sperm containing the Dpp10 
mutation identified above was recovered from the parallel Harwell sperm archive and 
used in IVF with C3H females to obtain live mice carrying this Dpp10 mutation. 
Progeny born following IVF were genotyped using a diagnostic restriction enzyme 
digest followed by PCR as follows: (i) 60 s at 94 °C, (ii) 60 s at 55 °C and (iii) 30 s at 
72 °C for 32 cycles. PCR products were digested with the HPYChe4IV enzyme (2u 
for 3 hours), then run on a 2% agarose gel to determine the size of products. The 
mutant Dpp10 band was 194 bp and wild-type DNA was cut into 2 fragments of 127 
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and 62 bp.  We subsequently established a congenic Dpp10 line by backcrossing these 
mice to CH3 for 10 generations.  
 
 
Histology and immunostaining of lung tissues 
Adult human lung tissue was obtained from the Biobank of the Respiratory 
Biomedical Research Unit (BRU), Royal Brompton and Harefield NHS Foundation 
Trust. The study was approved by the Trust’s Ethics Committee (ethics reference 
number 10/H0504/9). Informed written consent was obtained from all study subjects. 
Control samples were obtained from healthy, non-asthmatic volunteers. Four 
micrometer parafﬁn sections or 10 micrometer cryosections were stained with 
haematoxylin and eosin (H&E), Mauritius scarlet blue (MSB) to identify collagen or 
immunostained using previously established protocols (15) Lung tissue processing 
and immunohistochemistry were performed as previously described (16). Antibody 
dilutions were: aquaporin-5 1:400, CC-10 1:500, Santa Cruz; pro-SP-C 1:1000, 
Chemicon; alpha smooth muscle actin (SMA) 1:1000, Lab Vision. Incubations were 
overnight at 4oC. For CC10 immunostaining, antigen retrieval using citrate buffer 
(PH6) was required to unmask antigens prior to immunodetection. Antibodies were 
detected with either universal (alpha SMA, pro-SP-C) or goat (CC10, Aquaporin-5) 
ABC elite staining kit (Vector Labs). Rabbit anti DPP10 was obtained from Santa 
Cruz Biotechnology (sc-174156) or Aviva Systems Biology (OAAB05596) and used 
at 1:100 dilution. Controls, where the primary antibody was omitted, were included in 
each immunostaining experiment. 
 
Quantifying percentage of airway cells with apical Dpp10 immunostaining 
The total number of cells in individual airways was determined by counting the 
number of haemotoxylin stained nuclei. The percentage of cells with apical Dpp10 
staining in each airway was determined by expressing the number of cells with brown 
staining visible at the apical surface of cells (i.e. immediately adjacent to the lumen) 
as a percentage of total airway cells. 8 airways from n=3 mice per group were 
analysed.  
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Allergen sensitization 
8-10 week old mice (no more that 1 week difference in age within any one 
experiment) were dosed with purified HDM extract (Greer Laboratories, NC, USA, 
batch number 7500: 21.26g derP/mg protein; 13.55 endotoxin U/mg) intranasally 
(1g/l in 25l Phosphate-buffered saline (PBS) 3 times/week for 3 weeks, littermate 
control mice received PBS only. Lung function testing was carried out 24hr following 
the last dose. 
 
Measurements of airway hyperresponsiveness (AHR) 
Unrestrained conscious mice (male and female) were placed into a plethysmograph 
chamber (Buxco Europe Ltd., Hampshire, UK). Airway resistance was measured as 
Penh (enhanced pause) (17). Baseline Penh was measured for 5 min, after which time 
an aerosol of methacholine (Sigma-Aldrich, Dorset, UK) was given and Penh was 
again measured for 5 minutes. The change in Penh was calculated between baseline 
and each subsequent methacholine dose. 
  Respiratory mechanics were also directly measured using the forced 
oscillation technique (Flexivent system, SCIREQ) in anaesthatized, ventilated female 
mice 24 hours post-challenge. Following lung function measurements serum, BALF 
and lung tissue samples were collected and processed based on the method by 
Hamelmann et al (18). BALF was collected using 3 x 0.4ml sterile PBS, and 
centrifuged. The supernatant was stored for further analysis, and the cell pellet was re-
suspended in 0.5ml RMPI supplemented with 10% FBS, penicillin and streptomycin. 
50,000 cells were spun at 400 rpm for 4 min using a Cytospin3 (Shandon), and fixed 
in methanol for 5 min. Cells were stained using Wright-Giemsa stain (Sigma-Aldrich) 
following manufacturer’s instructions. Eosinophil percentages were obtained by 
determining the number of eosinophils in a sample of 300 cells per mouse. Left lung 
lobes were inflated and fixed for histology as detailed above.  
 
Quantification of peribronchiolar collagen and goblet cell counts in lung tissue 
samples 
To quantify collagen around the airways, 4 µm wax sections were stained with Sirius 
red. Digital images were obtained from airways that were similar in size using a 40x 
lens under polarised light. All images were obtained in one sitting to minimise any 
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variability. For each image, a threshold was used so only the Sirius red staining was 
highlighted, and the integrated density of staining around each airway was 
determined. Image analysis was performed using Fiji software. For each mouse four 
airways were measured and the mean average was calculated. 
Goblet cells counts were obtained using the protocol described in Townsend et 
al. (19). Periodic Acid-Schiff (PAS)-stained goblet cells in airway epithelium were 
counted in 4 µm wax lung sections. Counting was undertaken blind using a numerical 
scoring system (0: 5% goblet cells; 1: 5 to 25%; 2: 25 to 50%; 3: 50 to 75%; 4: >75%) 
The sum of airway scores from each lung was divided by the number of airways 
examined, 20–50 per mouse, and expressed as mucus cell score in arbitrary units (U). 
 
Cell culture of human bronchial airway epithelial cells 
Bronchial epithelial transformed cells (BEAS-2B) were purchased from LGC 
standards (Teddington, UK) no contamination was found in the cell stock. The cells 
were cultured in keratinocyte media, supplemented with recombinant human 
epithelial growth factor (rhEGF) and bovine pituitary extract (BPE) (all Gibco, 
Paisley, UK) as previously described (20). Following overnight culture in minimal 
media to enable synchronization, cells were stimulated with IL-1β (10ng/ml, Sigma 
Aldrich) or dexamethasone (Sigma Aldrich) and proteins isolated at 2h or 24h for 
analysis of supernatants by ELISA.  Proteins were extracted from cells using a nuclear 
extraction kit (Active Motif, Rixensaart, Belgium) following manufacturers 
instructions. 
 
 
Knockdown and overexpression of DPP10 in BEAS2B cells  
DPP10 gene expression was knocked down using 50nM ON-TARGET plus SMART 
pool siRNA (Thermo-Scientific Dharmacon, CO, USA) against the DPP10 gene as 
described previously (20).  Silencer select siRNA (Ambion, TX, USA) was used as a 
control for transfection.  The DPP10 clone 11 (1) was overexpressed using jetPEI 
(Polyplus-transfection, Illkirch, France) according to the manufacturer’s instructions.  
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Knockdown of DPP10 in NHBE cells 
Primary human bronchial epithelial (NHBE) cells were obtained from Lonza and no 
contamination was found in the cell stock. The cells were cultured to a maximum of 
five passages to limit variable responses in bronchial epithelial medium (hAEC 
Culture Medium . Epithelix). Cells were seeded into 24-well plates (Corning Costar 
Corp.) at 4x104 cells/well to reach 40–60% confluence on the day of transfection. 
RNA interference (RNAi) was carried using 150nM ON-TARGETplus SMARTpool 
(Dharmacon Research Inc., Lafayette, CO) or ON-TARGETplus Non-targeting Pool 
negative control. RNAi-complexes were added to the cells were placed in a CO2 
incubator at 37°C for 48 hours. Following transfection, culture medium was changed 
and then stimulated with 1 ng/ml of IL-1. Cells Supernatants were collected at 
different time points post-stimulation (0h, 4h, 10h, 16h, 24h and 30h) for cytokines 
measurement. qPCR primer sequences were as follows: DPP10 forward primer 
GTGAAGGTCCAAGGGTC; reverse primer CTGGCTTTCCTATCTTCTTC. 
GAPDH forward primer: TCAAGAAGGTGGTGGTGAAGCAG; reverse primer 
CGCTGTTGAAGTCAGAGGAG.  
 
Enzyme-linked immunosorbent assays (ELISA)  
Levels of Secretory Leukocyte Protease Inhibitor (SLPI) in the supernatant, 
were measured by ELISA following manufacturer’s instructions (R&D systems, 
Minneapolis, MN, USA), 24 hours following cell stimulation. Human IL-6 and IL-8 
were measured by ELISA DuoSet (R&D Systems Europe; Abingdon, Oxon, UK), 
according to the manufacturer’s instructions. Mouse serum IgE levels were measured 
by ELISA assay using purified anti-mouse IgE capture antibody (BD Pharmingen Cat 
No 553413), according to the manufacturer’s instructions.  
 
Western Blotting 
Western Blotting was performed as described previously (20) using an anti-
glucocorticoid receptor (GR) antibody (H-300, Santa Cruz Biotechnology), 1:1000 
and visualised using LuminataTM Forte solution (Millipore, Billarica, MA USA) with 
exposure to X-ray film (Fisher Scientific, Loughborough, UK).  
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Statistical analysis 
Graphs were generated using GraphPad Prism software (GraphPad version 5.0, La 
Jolla, CA, USA) or Microsoft Excel. Where appropriate, sample sizes were 
determined using power calculations based on previous experimental data. Data are 
expressed as mean ± standard error of Mean (SEM). Data on resistance, elastance and 
compliance at 100mg/ml of methacholine and ΔPenh at 50 mg/ml methacoline are 
expressed as box and whisker plots showing median and interquartile range. For 
house dust mite challenge experiments, statistical significance of HDM-treated vs 
PBS control groups in wild-type and Dpp10145D mice was determined by a two-tailed 
P value using the Mann–Whitney U test when comparing between two groups only. 
For knockdown experiments in human cells, graphs show mean values ± SEM of 
SLPI, IL-6 and IL-8 between DPP10 knockdown cells and control cells. Differences 
between groups were tested using a two-tailed Student's t-test. A P-value of < 0.05 
was considered significant for all statistical analyses. 
 
 
RESULTS 
Mouse Dpp10 genomic structure  
We identified the full-length mouse cDNA of Dpp10 and aligned this with available 
information on Dpp10. Mouse genomic Dpp10 is located on chromosome 1 and has 
26 exons encoding 796 amino acids. The key domains found within the sequence are a 
trans-membrane domain and a β-propeller region (Supplemental figure 1).  We 
therefore screened the ENU DNA archive for mutations within exons encoding either 
of these domains. 
 
Identifying and validating ENU mutations in Dpp10  
From this initial screening, we identified three mutations in 3480 DNA samples. The 
only non-synonymous mutation found caused an amino acid change from valine to 
aspartic acid in exon 5 (Figure 1A, B). The valine, or at least a hydrophobic residue at 
this position, is well conserved in DPP10 and DPP6 orthologous sequences 
throughout vertebrates (Figure 1C).  The wider family of DPPIV domain containing 
proteins do not generally conserve this position, but aspartic acid (D) has not been 
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found in any of the proteins defined by the Protein FAMilies database of alignments 
and Hidden Markov Models (PFAM) profile (21).  The mutated residue is on the 
surface of the protein at the entrance to a pocket in the centre of the β-propeller 
region. A surface exposed hydrophobic residue in such a position may well be 
involved in determining substrate specificity and therefore a mutation in this position 
is highly likely to have some functional impact on DPP10. 
 
Recovery and maintenance of Dpp10 mutant mice 
To determine whether the mutation identified would have an impact on DPP10 
function in vivo, we established a mouse line carrying this mutation, using the 
corresponding F1 male sperm sample from the Harwell DNA archive (14). In vitro 
fertilization with the mutagenized sperm was performed using C3H embryos to 
facilitate genotyping of the mutation that had been induced in Balb/C mice. We 
established a genotyping strategy using an enzymatic diagnostic digest with 
HpyChe4IV, followed by PCR to distinguish mutant mice from wild-type littermates 
(Figure 1D). Seven offspring were obtained, six of which contained the mutant allele 
indicating that a single copy of the mutation did not affect mouse viability or fertility. 
We subsequently established a congenic Dpp10 line by backcrossing these mice to 
CH3 for 10 generations; thereby ensuring that the line did not contain any additional 
ENU mutations. Dpp10 heterozygotes were intercrossed and the genotypes of their 
offspring were analysed at E18.5. Normal Mendelian ratios of homozygous, 
heterozygous and wild-type embryos were found, indicating no prenatal mortality and 
this was confirmed by Chi squared analysis. Postnatally, Dpp10145D homozygotes and 
heterozygotes were also recovered in expected numbers and these were 
morphologically indistinguishable from wild-type littermates. All subsequent 
experiments were conducted using either homozygous Dpp10 mice or their wild-type 
littermates.  
 
Histological examination of Dpp10 mutant mouse lungs 
Dpp10145D homozygotes survived to term and histological analysis did not reveal any 
visible differences in adult lung architecture (Supplemental figure 2). We investigated 
the localisation of Dpp10 protein in both wild-type and homozygous Dpp10 mutant 
lungs by immunostaining. In PBS treated wild-type and Dpp10145D/145D lungs showed 
a sub-set of airway epithelia cells with Dpp10 positive staining (Figure 2A, B).  
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Dpp10 staining was much more visible in the airways of both wild-type and mutant 
mice treated with HDM (Figure 2 C, D). Staining of sections from the same samples 
shown in C and D with CC10, a Club cell marker, highlights differences in the 
patterns of Dpp10 and CC10 staining (Figure 2 E, F). The discrepancy is particularly 
striking in Dpp10 homozygous airways (Figure 2 D vs F). More detailed comparison 
of Dpp10 localisation in wild-type and Dpp10145D airway cells showed that in wild-
type airways, staining was frequently observed at the apical surface of cells whereas 
in mutant airways, cells with apical Dpp10 staining were much rarer (P < 0.05, Figure 
2F). This data indicates that the point mutation in Dpp10145D leads to altered protein 
localisation rather than complete loss of protein.  Further analysis of the lungs showed 
no visible difference in the cell-type specific markers pro-Surfactant protein-C, Club 
Cell-10 protein, Smooth muscle actin or Aquaporin-5 between Dpp10 homozygotes 
and wild-type mice (Supplemental figure 3), indicating that the Dpp10 mutation does 
not affect cell differentiation. 
 
The response of Dpp10 mutant mice to house dust mite challenge   
To determine whether the Dpp10145D mutation had a functional impact and in 
particular, whether the mutation might modify airway hyper-responsiveness, we dosed 
wild-type (n = 9) and Dpp10 homozygous (n = 10) mice with 25g house dust mite 
extract (HDM) 3 times per week for 3 weeks using a previously established protocol 
(22). Mice were then challenged using a methacholine dose response curve 24 hours 
after the final HDM dose. Airway responsiveness was initially assessed in a whole-
body plethysmograph, using Penh. At baseline and at lower doses of methacholine 
(12.5 and 25 mg/ml), we found no significant difference in Penh between wild-type 
and Dpp10 homozygotes (Supplemental Figure 4A), however at the highest dose of 
Penh tested (50 mg/ml), Dpp10 homozygotes showed a significant increase in Penh 
(supplemental figure 4B) (P < 0.05).  
Following plethysmograph experiments, which indicated increased airway 
resistance in Dpp10 homozygous mice, we conducted a further HDM challenge prior 
to directly test respiratory function using the forced oscillation technique (Flexivent). 
Dpp10 HDM treated mutant mice showed significantly increased airway resistance in 
response to methacholine challenge (Figure 3A) at 100mg/ml compared to wild-type 
HDM treated mice (P < 0.05, Figure 3B). Dpp10 HDM treated mutant mice also 
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showed significantly increased elastance (Figure 3C Vs D, P < 0.05) and decreased 
compliance (Figure 3E Vs F, P < 0.05) in response to methacholine challenge at 
100mg/ml compared to wild-type HDM treated mice.  
To analyse the response of Dpp10 homozygous mice to allergen challenge 
further, we assessed a number of hallmarks of allergic airways disease.  IgE levels in 
serum of HDM treated Dpp10145D mice were significantly higher compared to wild-
type HDM treated littermates (Figure 4A, P < 0.05). We also found an increased 
percentage of eosinophils in BALF of Dpp10145D/145D HDM treated mice compared to 
the wild-type HDM group (Figure 4B, P < 0.05). Quantification of collagen thickness 
around airways showed a trend towards increased thickness in Dpp10145D 
homozygotes, however this was not statistically significant (Figure 4C, D). We did 
not observe and noticeable difference in goblet cell numbers across all groups of mice 
(Figure 4E, F).  
 
DPP10 protein is present in human asthmatic airway epithelial cells and 
modulation of DPP10 affects key inflammatory mediators 
In order to investigate the possible functional roles of DPP10 in human lungs, we also 
investigated DPP10 expression in asthma patients. In agreement with our findings in 
mouse, we found very little DPP10 protein in the bronchial airway epithelium of 
healthy subjects while in contrast expression was enhanced in epithelium of asthmatic 
patients (Figure 5A).  As with the murine data, DPP10 was only seen in some 
epithelial cells.  
Data from the murine model indicated a potential protective role of DPP10 in 
the airways so we investigated the effects of DPP10 knockdown and overexpression 
in human bronchial epithelial cells (BEAS-2B). DPP10 siRNA effectively silenced 
the expression of DPP10 (Figure 5B).  Knockdown of DPP10 enhanced IL-1-
induced leukocyte proteinase inhibitor (SLPI) release from BEAS-2B cells although 
this did not reach significance (Figure 5C).  In contrast, overexpression of DPP10 
resulted in a significant reduction in IL-1-induced SLPI release (Figure 5C).  As the 
functional effect of DPP10 in vivo suggested a possible effect on endogenous anti-
inflammatory corticosteroid production, we examined the effect of DPP10 
modulation on the glucocorticoid receptor (GR). DPP10 knockdown attenuated the 
ability of GR to translocate to the nucleus and bind to DNA whereas DPP10 
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overexpression significantly enhanced GR activation even without dexamethasone 
treatment (Figure 5D).  This data was confirmed by Western blot analysis of GR 
nuclear translocation in BEAS-2B cells (Figure 5D lower panels). 
To further investigate whether DPP10 could modulate cytokine release, we 
also conducted siRNA mediated knockdown of DPP10 in primary epithelial cells 
(Normal Human Bronchial Epithelial Cells, NHBE). Knockdown with 150nM DPP10 
siRNA for 48hr resulted in a 66 percent reduction in DPP10 transcript levels, 
compared to control.  Following siRNA knockdown, NHBE cells were stimulated 
with IL1 and the levels of IL8 (Figure 5E) and IL-6 (Figure 5F) released from 
control and DPP10 knockdown cells were measured at 0, 4, 10, 16, 24 and 30 hours 
following stimulation. DPP10 knockdown increased the level of IL-8 and IL-6 
released from NHBE cells at 24 and 30 hours (the increase was statistically significant 
for IL-8 but not IL-6).  These results are consistent with the idea that Dpp10 plays a 
protective role in asthma 
 
DISCUSSION 
Using a Dpp10 point mutant, with a valine to aspartic acid change in the β propeller 
region, we demonstrated that homozygous mutant mice exhibit greater AHR 
following HDM challenge than wild-type animals.  We also find that DPP10 protein 
is present in airway epithelial cells and Dpp10 immunostaining is increased in mice 
following HDM challenge; this corresponds with clinical findings where asthmatic 
patients show increased DPP10 in lungs compared to controls.  Modulation of DPP10 
in BEAS2B and NHBE cells resulted in altered levels of cytokine release following 
IL-1 stimulation as well as modified glucocorticoid function. These results provide 
biological evidence to support previous findings from human genetic studies 
indicating that DPP10 is an asthma susceptibility gene.  
Positional cloning and Genome wide association studies (GWAS) have 
identified several genes that are associated with asthma.  Understanding the functions 
of these genes is an important next step to shed light on the aetiology of asthma.  This 
is particularly important for genes like Dpp10, where very little is known about their 
biological function in the lungs (23). The association of DPP10 with asthma has been 
confirmed across several different ethnic populations (2-6). In addition, recent studies 
have shown that DPP10 genetic variants may affect lung function decline in aging 
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(24), and have also been associated with aspirin-exacerbated respiratory disease (10). 
DPP10 is a potassium channel associated protein (25, 26) but unlike other DPP family 
members, mammalian DPP10 lacks enzymatic activity and is unable to cleave 
terminal dipeptides from asthma-related cytokines and chemokines (1). Interestingly 
however, in Drosophila DPP10 acts both as an ion channel substrate and has 
peptidase activity (27).  
DPP proteins contain a β-propeller domain, which regulates substrate access to 
an α/β hydrolase catalytic domain. Most interactions of DPP10 with other proteins are 
likely to occur on the -propeller domain so it is significant that the mutation in 
Dpp10145D is in this domain (25). In the brain, DPP10 malfunction is associated with 
neurodegenerative conditions like Alzheimer and fronto-temporal lobe dementia. 
Moreover, DPP10 variants in neurons have been shown to alter potassium channel-
gating kinetics (28) and additional studies have shown that DPP10 modulates the 
electrophysiological properties, cell-surface expression and subcellular localization of 
voltage-gated potassium channels (29). Given the location of the mutation in the 
Dpp10145D mouse line, it is tempting to speculate that ion channel gating kinetics may 
also be altered in the lungs of these mice. 
Like human DPP10, mouse Dpp10 has 26 exons and multiple splice variants, 
which retain the transmembrane domain and β-propeller domains. Mouse ENU 
mutagenesis has proved to be a powerful tool for studies of human diseases, 
particularly prior to the discovery of Crispr/Cas9 gene editing techniques. Through 
backcrossing, mice harbouring the selected mutation on a congenic background can 
be obtained (30).  In the current experiment, we identified one non-synonymous 
mutation, resulting in an amino acid change from valine to aspartic acid in the β-
propeller domain of Dpp10.  Careful comparison of embryonic Dpp10 homozygotes 
and wild-type littermates did not reveal any visible phenotype indicating the 
Dpp10145D mutation does not affect the development of mouse lungs. 
In this study, we found that mouse DPP10 is localized to the airway 
epithelium, and more Dpp10 is visible in airways, after HDM treatment. This finding 
is consistent with a previous report showing Dpp10 protein in the airway epithelium 
of rat lungs (9). Comparison of airways stained for Dpp10 and CC10, a marker of 
Club cells, indicates that not all Club cells are positive for Dpp10, since CC10 stained 
cells are more prevalent than Dpp10 positive cells. Our data does indicate that at least 
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some CC10 positive cells are also positive for Dpp10. However, further investigation 
with additional cell-type specific markers will be required to determine which sub-
type(s) of airway epithelial cells express Dpp10 e.g. Basal cells, Ciliated cells etc. 
Comparison of the sub-cellular pattern of CC10 staining with that of DPP10 did 
reveal differences in localisation of these two proteins. Moreover, the localisation of 
Dpp10 protein is different in airways of wild-type and Dpp10145D; there are 
significantly fewer cells with Dpp10 at the apical surface in mutant lungs. These 
observations indicate that loss of function in the Dpp10145D mice is likely to result 
from altered protein function rather than lack of protein. This is a frequent 
consequence of point mutations in both mouse models and in the human population 
(31, 32). 
  HDM is one of the commonest aeroallergens worldwide and up to 85% of 
asthmatics are typically HDM allergic. Inhalation of HDM by naïve mice results in 
lung function changes including increased resistance and reduced compliance as well 
as recruitment of inflammatory leukocytes (22, 33). HDM challenge initiates a Th2-
polarized response with T2 helper cytokines being produced in both BALF and lungs 
of mice, including IL-4, 5 and 13 and typically an influx of eosinophils and increase 
in IgE levels. This cytokine response is important driving the development of airway 
remodelling which occurs after the Th2 cytokine response and altered lung function 
(22, 34).  
Our results show that after HDM challenge, Dpp10 homozygotes display 
significantly increased AHR upon methacholine challenge compared to wild-type 
littermates. Specifically resistance and elastance are increased and compliance is 
reduced. Following HDM treatment, serum IgE levels and eosinophil counts in BALF 
were significantly higher in Dpp10 mutants after HDM treatment. Although collagen 
thickness and goblet cells were not significantly increased, it is known that these 
hallmarks of airway remodelling only become significantly altered after a longer and 
more frequent HDM dosing regimen than the one used here (22, 33, 35).   
In asthmatics, exposure to the allergen HDM triggers the release of cytokines 
as a result of mite-derived protease activity (36). Anti-proteases such as SLPI can 
inhibit this cytokine release.  SLPI is an anti-inflammatory gene induced by 
glucocorticoid in human epithelial cells and low SLPI has been associated with severe 
asthma in mice and humans (37, 38) In this study we showed that DPP10 
overexpression in BEAS2B cells results in lower levels of SLPI release following 
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cytokine stimulation and enhanced corticosteroid activity. In combination with our 
finding that DPP10 knockdown in primary human bronchial epithelial cells leads to 
increased IL-8 and IL-6 release, these data demonstrate that alterations in DPP10 
levels can modify the inflammatory response in lung epithelial cells.  
In summary, we have established a congenic mouse line harbouring a mutation 
in the β-propeller domain of DPP10. Our data provide functional experimental 
evidence supporting previous human genetic data indicating DPP10 is an asthma 
susceptibility gene. Results from both murine and human in vivo and in vitro analysis 
suggest that DPP10 may play a protective role in asthma.  The novel Dpp10 mouse 
mutant reported here provides a means to investigate the functional roles of Dpp10 in 
vivo, for the first time.  Understanding how the mutant Dpp10 Kv4 ion channel 
complex is impacted by the DPP10145D mutation and how this affects other 
inflammatory associated factors such as TGF-β and IL-33 will be important future 
studies.  
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Figures 
 
 
 
Figure 1: The Dpp10 mutation and genotyping in mice 
(A)Wild-type sequence for Dpp10.  (B) Mutant sequence of Dpp10. (C) Alignment of 
the sequences containing the first β-propeller of DPP10 across seven species. (D) Gel 
comparing the genotyping results from wild-type (left lane) and heterozygous (right 
lane) Dpp145D littermates. Using the following primers: 
 Forward, AGTCTTGTCTTTACCACA and Reverse, AAGCCTCCAGACACTCAC, 
PCR generated a 194 bp product. Restriction enzyme digest with HPYChe4IV cut the 
wild-type allele at ACGT producing two bands of 127bp and 67 bp, whilst the mutant 
allele remained uncut (194 bp). WT: Wild-type mouse, M: mutant mouse.  
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Figure 2: Dpp10 localization in mouse airways 
Dpp10 positive staining is present some airway epithelial cells in both wild-type (A) 
and homozygous (B) lungs, red arrows indicate examples of positively stained 
cells.  Treatment with house dust mite (HDM) resulted in increased DPP10 staining in 
both genotypes (C), (D). In wild-type mice Dpp10 positive staining was frequently 
present at the apical surface of airway epithelial cells (blue asterisks) (C). In 
Dpp10145D homozygotes, few cells with apical Dpp10 staining were present, in 
contrast, strong staining was frequently observed more basally (black asterisks) (D). 
Many cells in both WT (E) and Dpp10145D homozygous airways (F) are positive for 
the Club cell marker CC10. Haemotoxylin stained control airways with primary 
antibody omitted (E).  Quantification of cells with apical Dpp10 staining from 8 
airways in N= 3 mice per group (F), mean ± SEM, Student’s t-test, P < 0.001 for WT 
vs Dpp10145D PBS treated mice and P<0.05 for WT vs Dpp10145D HDM treated mice. 
Scale bar = 12.5M. a = airway lumen,   
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Figure 3: Following House Dust Mite challenge, Dpp10 homozygous mice show 
increased airway hyperresponsiveness compared to wild-type littermates 
Lung function was measured using the FlexiVent system. The effect of methacholine 
on airway resistance (A, B), airway elastance (C, D) and airway compliance (E, F) is 
shown.  Dose response curves are shown in (A), (C) and (E), mean ± SEM. Airway 
resistance (B), airway elastance (D) and airway compliance (F) at 100 mg/ml 
methacholine shown in detail. Box and whisker plots depict the median and 
interquartile range (IQR).  N = 4 mice for PBS groups, N = 6 for HDM groups, Mann-
Whitney U test * P < 0.05. 
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Figure 4:  Dpp10 homozygous mice develop allergic inflammation in the lungs 
after house dust mite (HDM) challenge 
Exposure of Dpp10 homozygotes to HDM resulted in enhanced serum IgE levels (A) 
and elevated eosinophil counts in bronchoalveolar lavage fluid (BALF) (B) compared 
to wild-type littermates.  Dpp10 homozygotes showed a non-significant trend towards 
increased peribronchiolar collagen (C, D) and goblet cell numbers compared to wild-
type littermates (E, F).  Data represented as mean ± SEM, N=4 mice for all groups of 
IgE (A); eosinophil percentage N=4 for WT PBS, WT HDM and Dpp10 PBS groups, 
N=6 for Dpp10 HDM group (B). Sirius Red N=4 for WT PBS, Dpp10 PBS and 
Dpp10 HDM groups, N=6 for WT HDM group (C). Goblet cell numbers N=3 for WT 
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and Dpp10 HDM groups (E).  Mann-Whitney U test  * P < 0.05; *** P < 0.001. Scale 
bars: D=12.5M, F=25M.  
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Figure 5: DPP10 is increased in human asthmatic airways and modulates release 
of Inflammatory mediators from human airway epithelial cells 
Representative immunohistochemical staining of bronchial biopsies from asthmatic 
and normal healthy subjects are shown in (A).  Results are representative of samples 
from 3 subjects. A concentration-dependent reduction in DPP10 protein expression 
after 24hrs in BEAS-2B cells following siRNA knockdown (B).  DPP10 
overexpression suppresses IL-1-induced SLPI release from BEAS-2B cells whereas 
DPP10 knockdown results in an increase in SLPI release (C).  DPP10 knockdown 
also attenuates the ability of the glucocorticoid receptor (GR) to be activated by 
dexamethasone (D) whereas DPP10 overexpression enhanced GR DNA binding.  The 
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lower panel shows representative Western blots of GR translation. IL8 levels in 
supernatants from DPP10 knockdown NHBE cells and control cells after 0 to 30 
hours stimulation of IL1β (E). IL6 levels in supernatants from DPP10 knockdown 
and control cells NHBE cells after 0 to 30 hours stimulation of IL1β (F). Results are 
expressed as mean ± SEM of 3 or 4 independent experiments. Students t-test, *** P < 
0.001 versus control, ### P < 0.001, ## P < 0.01 and # P < 0.05 versus stimulated 
samples.   
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Supplemental figure S1.  The amino acid sequence and structural features of 
mouse DPP10. 
Supplemental Figures 
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Supplemental figure S2. Lung histology of wild-type and DPP10145D/145D
littermates.  
H&E staining of mouse airways (A, C) following WT PBS, (E, G) WT HDM, (B, D) 
Dpp10145D homozygous PBS, (F, H) Dpp10145D homozygous HDM treatments. 
Scale bars: A, B, E, F 25µM, C, D, G, H 12.5µM. a = irway lumen. 
Disease Models & Mechanisms 11: doi:10.1242/dmm.031369: Supplementary information
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Supplemental figure S3. Comparison of cell-type specific markers in wild-type 
and Dpp10145D/145D and littermates. 
Immunohistochemical staining for (A,B) the type II alveolar epithelial cell marker 
Pro-surfactant C, (C,D) smooth muscle actin, (E,F) Club Cell 10 for Clara cells and 
(G,H) aquaporin 5 for type I alveolar epithelial cells. No significant differences were 
visible between wild-type (A,C,E,G) and homozygous (B,D,F,H) mouse lungs. 
Control sections were processed simultaneously with A-H but with the primary 
antibodies omitted, representative examples of control sections for anti-rabbit/mouse 
universal staining kit (I) and anti-goat staining kit (J) are shown. Scale bars A-H = 
12.5 µM. 
Disease Models & Mechanisms 11: doi:10.1242/dmm.031369: Supplementary information
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Supplemental figure S4. Comparison of Penh in wild-type and Dpp10145D/145D
littermates following house dust mite challenge 
Lung function measured in unrestrained conscious mice placed in a plethysmograph 
chamber. N= 9 for WT and N=10 for Dpp10145D. ΔPenh in wild type and DPP10 
mutant mice in response to increasing doses of methacholine (A).  ΔPenh at 50mg/ml 
methacholine (B). * P < 0.05, determined by Mann–Whitney U test. 
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Table S1. PCR primer sequences for Dpp10 exons. 
Exon 
Length 
Forward Primer Sequence Reverse Primer Sequence PCR 
Products 
Sizes 
Exon 2 107 GAAACCACAAAGAACGACC AAGAAAATAGACTGTACTCC 400 
Exon 5 75 TTGCTAGTCAACCATCTC TTCCATTTCAGATTATTTGAC 342 
Exon 6,  7 55, 82 GGCAAGTGCTTTCCCTAC AGAGACAGAGCTATGCAC 623 
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